Inovio appoints VP, oncology
This article was originally published in Scrip
Inovio Pharmaceuticals has appointed Dr Zane Yang vice-president of clinical development, oncology. In this position, he will be responsible for advancing Inovio's oncology portfolio of DNA immunotherapies through clinical trials to commercialization. He will report to Dr Mark Bagarazzi, Inovio's chief medical officer. Dr Yang joins Inovio from Janssen Pharmaceuticals, a unit of Johnson & Johnson, where he was director, oncology medical affairs in the US.